Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Beauty Health (SKIN) EBITDA Margin (2021 - 2025)

Historic EBITDA Margin for Beauty Health (SKIN) over the last 5 years, with Q3 2025 value amounting to 15.02%.

  • Beauty Health's EBITDA Margin rose 66900.0% to 15.02% in Q3 2025 from the same period last year, while for Sep 2025 it was 3.25%, marking a year-over-year increase of 44600.0%. This contributed to the annual value of 9.88% for FY2024, which is 149000.0% up from last year.
  • As of Q3 2025, Beauty Health's EBITDA Margin stood at 15.02%, which was up 66900.0% from 29.85% recorded in Q2 2025.
  • Beauty Health's EBITDA Margin's 5-year high stood at 41.52% during Q1 2022, with a 5-year trough of 317.96% in Q3 2021.
  • In the last 5 years, Beauty Health's EBITDA Margin had a median value of 10.23% in 2023 and averaged 35.92%.
  • Per our database at Business Quant, Beauty Health's EBITDA Margin soared by 3160300bps in 2022 and then crashed by -749700bps in 2023.
  • Over the past 5 years, Beauty Health's EBITDA Margin (Quarter) stood at 26.51% in 2021, then skyrocketed by 134bps to 8.89% in 2022, then plummeted by -185bps to 7.58% in 2023, then plummeted by -114bps to 16.25% in 2024, then rose by 8bps to 15.02% in 2025.
  • Its EBITDA Margin was 15.02% in Q3 2025, compared to 29.85% in Q2 2025 and 12.89% in Q1 2025.